BCLI – Brainstorm Cell Therapeutics, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.31
Float Short %
1.93
EPS 1 Diff
0.01
EPS Year Diff
5.82
Ticker: BCLI
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2024-09-06 | BCLI | 0.2558 | 0.31 | 0.00 | 5543 |
2024-09-09 | BCLI | 0.2741 | 0.31 | 0.00 | 5543 |
2024-09-10 | BCLI | 0.2733 | 0.31 | 0.00 | 5553 |
2024-09-11 | BCLI | 0.279 | 0.31 | 0.00 | 5553 |
2024-09-12 | BCLI | 0.275 | 0.31 | 0.00 | 5553 |
2024-09-13 | BCLI | 0.2793 | 0.31 | 0.00 | 5555 |
2024-09-16 | BCLI | 0.266 | 0.31 | 0.00 | 5555 |
2024-09-17 | BCLI | 0.262 | 0.31 | 0.00 | 5555 |
2024-09-18 | BCLI | 0.24 | 0.31 | 0.00 | 5570 |
2024-09-19 | BCLI | 0.2402 | 0.31 | 0.00 | 5570 |
2024-09-20 | BCLI | 0.247 | 0.31 | 0.00 | 5570 |
2024-09-23 | BCLI | 0.2402 | 0.31 | 0.00 | 5570 |
2024-09-24 | BCLI | 0.2471 | 0.31 | 0.00 | 5568 |
2024-09-25 | BCLI | 0.2413 | 0.31 | 0.00 | 5568 |
2024-09-26 | BCLI | 0.2514 | 0.31 | 0.00 | 5571 |
2024-09-27 | BCLI | 0.2277 | 0.31 | 0.00 | 5571 |
2024-09-30 | BCLI | 0.2284 | 0.31 | 2.33 | 5569 |
2024-10-01 | BCLI | 3.26 | 0.31 | 2.33 | 5569 |
2024-10-02 | BCLI | 2.66 | 0.31 | 2.33 | 5569 |
2024-10-03 | BCLI | 2.38 | 0.31 | 0.00 | 5554 |
2024-10-04 | BCLI | 2.3 | 0.31 | 0.00 | 5554 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2024-09-06 | BCLI | 0.26 | 78.6 | 2.4 | -0.18 |
2024-09-09 | BCLI | 0.28 | 78.6 | -0.5 | -0.18 |
2024-09-10 | BCLI | 0.27 | 78.6 | 0.7 | -0.18 |
2024-09-11 | BCLI | 0.28 | 78.6 | 0.6 | -0.18 |
2024-09-12 | BCLI | 0.28 | 78.6 | 0.9 | -0.18 |
2024-09-13 | BCLI | 0.28 | 78.6 | 0.7 | -0.18 |
2024-09-16 | BCLI | 0.27 | 78.6 | 1.5 | -0.18 |
2024-09-17 | BCLI | 0.26 | 78.6 | 0.7 | -0.18 |
2024-09-18 | BCLI | 0.24 | 78.6 | 2.5 | -0.18 |
2024-09-19 | BCLI | 0.25 | 78.6 | 0.6 | -0.18 |
2024-09-20 | BCLI | 0.24 | 78.6 | 0.2 | -0.18 |
2024-09-23 | BCLI | 0.24 | 78.6 | 0.7 | -0.18 |
2024-09-24 | BCLI | 0.25 | 78.6 | 0.2 | -0.18 |
2024-09-25 | BCLI | 0.24 | 78.6 | 1.3 | -0.18 |
2024-09-26 | BCLI | 0.25 | 78.6 | -0.1 | -0.18 |
2024-09-27 | BCLI | 0.22 | 78.6 | 2.5 | -0.18 |
2024-09-30 | BCLI | 0.23 | 78.6 | 0.3 | -0.18 |
2024-10-01 | BCLI | 3.26 | 78.6 | 1.6 | -0.18 |
2024-10-02 | BCLI | 2.64 | 78.6 | 4.1 | -0.18 |
2024-10-03 | BCLI | 2.51 | 78.6 | 1.3 | -0.18 |
2024-10-04 | BCLI | 2.33 | 78.6 | 0.5 | -0.18 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2024-09-06 | BCLI | -0.86 | -0.71 | 2.23 |
2024-09-09 | BCLI | -0.86 | -0.71 | 2.23 |
2024-09-10 | BCLI | -0.86 | -0.71 | 2.23 |
2024-09-11 | BCLI | -0.86 | -0.71 | 2.23 |
2024-09-12 | BCLI | -0.86 | -0.71 | 1.78 |
2024-09-13 | BCLI | -0.86 | -0.71 | 1.78 |
2024-09-16 | BCLI | -0.86 | -0.70 | 1.78 |
2024-09-17 | BCLI | -0.86 | -0.70 | 1.78 |
2024-09-18 | BCLI | -0.86 | -0.70 | 1.78 |
2024-09-19 | BCLI | -0.86 | -0.70 | 1.78 |
2024-09-20 | BCLI | -0.86 | -0.70 | 1.78 |
2024-09-23 | BCLI | -0.86 | -0.71 | 1.78 |
2024-09-24 | BCLI | -0.86 | -0.71 | 1.78 |
2024-09-25 | BCLI | -0.86 | -0.71 | 1.93 |
2024-09-26 | BCLI | -0.86 | -0.71 | 1.93 |
2024-09-27 | BCLI | -0.86 | -0.71 | 1.93 |
2024-09-30 | BCLI | -0.86 | -0.71 | 1.93 |
2024-10-01 | BCLI | -0.86 | -0.71 | 1.93 |
2024-10-02 | BCLI | -7.46 | -0.71 | 1.93 |
2024-10-03 | BCLI | -7.46 | -0.71 | 1.93 |
2024-10-04 | BCLI | -7.45 | -0.71 | 1.93 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.04
Avg. EPS Est. Current Quarter
-0.03
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
-7.45
Institutional Transactions
-0.71
Beta
0.37
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value (Academic)
Quality Score
35
Growth Score
Sentiment Score
4
Actual DrawDown %
95.5
Max Drawdown 5-Year %
Target Price
30
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-3.4
Average EPS Est. Cur. Y
-0.18
EPS Next Y. (Est.)
-0.22
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
2.61
Return on Equity vs Sector %
339.8
Return on Equity vs Industry %
318.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
0.5
stock quote shares BCLI – Brainstorm Cell Therapeutics, Inc. Stock Price stock today
news today BCLI – Brainstorm Cell Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BCLI – Brainstorm Cell Therapeutics, Inc. yahoo finance google finance
stock history BCLI – Brainstorm Cell Therapeutics, Inc. invest stock market
stock prices BCLI premarket after hours
ticker BCLI fair value insiders trading